| Objective:Atherosclerosis(AS)is a serious hazard to human health,of which endothelial injury is the initiating factor.Endothelial-mesenchymal transition(EndMT)is involved in the early pathological process of AS,but the exact mechanism is still unclear.Adropin is a newly discovered secretory membrane-binding protein with protective effect on endothelial cells.The aim of this study was to investigate whether Adropin can alleviate AS and its molecular mechanism by inhibiting EndMT.Methods:Animal experiment:ApoE-/-(apolipoprotein E knockout)mice aged 8 weeks with C57BL/6J background were fed with high fat for 13 weeks to establish AS model,which were divided into three groups(n=11-14):(1)Normal dieting group(ND),given normal diet;(2)High fat dieting group(HFD),given high fat diet;(3)High fat dieting+Adropin group(HFD+Adropin),given high fat diet and intraperitoneal injection of Adropin 105μg/kg.d for 13 weeks.The aortic root was used to detect the lipid area in AS plaque by oil red O staining,and the plaque area was measured by HE staining.The whole aorta was used to detect relative mRNA expression of endothelial cell marker proteins,including leucocyte differentiation antigen(CD)31 and vascular endothelial cadherin(VE-cadherin),as well as mesenchymal cells marker proteins,including alpha-smooth muscle actin(α-SMA),smooth muscle 22alpha(SM22α)and fibroblast specific protein(FSP)-1 and Adropin by real-time fluorescence quantitative polymerase chain reaction(RT-PCR).Localized expression of CD31 and SM22αwas detected by immunofluorescence assay.Cell experiment:EndMT model was established by using human umbilical vein endothelial cells(HUVEC)cultured in vitro with 100mol/L hydrogen peroxide(H2O2).They were divided into four groups:control group,with normal culture;H2O2 group,with H2O2 intervention;Adropin group,incubation with30ng/ml of Adropin 10 minutes before H2O2 intervention;Adropin+TGF-βplasmid group,transfection of TGF-βplasmid before Adropin intervention.The number of spindle cells transformed from mesenchymal at day 0,2,4 and 6 after culture was counted.At the end of the experiment(day 6),the expression of transforming growth factor(TGF)-β1,TGF-β2,CD31,VE-cadherin,α-SMA,SM22αand phosphorylation level of signal protein Smad2/3 were measured by Western-Blot.The expression ofα-SMA was measured by immunofluorescence and the relative expression of RNA of TGF-β1,TGF-β2,TGF-βreceptor(TGF-βR),CD31,VE-cadherin,α-SMA,SM22α,FSP-1 were measured by RT-PCR.The level of reactive oxygen species(ROS)was measured by fluorescence.Serum total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),and triglyceride(TG)were detected by automatic biochemical analysis.Serum oxidized low density lipoprotein(ox-LDL)was detected by ELISA.Results:Animal experiment:Compared with ND group,high fat diet(HFD group)induced significant AS in ApoE-/-mice.The lipid area(oil red O staining)and plaque area(HE staining)of aortic root AS plaque in HFD group increased[oil red O staining,(0.06±0.02)%vs.(0.27±0.16)%,P<0.05;HE staining,(0.12±0.04)%vs.(0.30±0.08)%,P<0.05],Adropin(HFD+Adropin group)can alleviate AS caused by high fat feeding[oil red O,HE staining,respectively(0.04±0.03)%and(0.10±0.08)%,all P<0.05].Compared with ND group,HFD group showed significant mesenchymal transformation of vascular endothelium in HFD group,which showed that the expression of RNA of CD31 and VE-cadherin in aorta decreased[CD31,(1.71±0.68)vs.(0.23±0.34),P<0.05;VE-cadherin,(11.24±5.44)vs.(0.36±0.51),P<0.05],the expression ofα-SMA and FSP-1 increased[α-SMA,(0.03±0.01)vs.(2.34±0.99),P<0.05,FSP-1,(0.27±0.17)vs.(1.92±0.60),P<0.05],Compared with HFD group,Adropin reduced vascular endothelial-mesenchymal transition[HFD+Adropin group:CD31,(1.54±0.18),P<0.05;α-SMA,(0.15±0.24),P<0.05;FSP-1,(0.29±0.30),P<0.05].Compared with ND group,the expression of Adropin was increased in HFD group,and the expression of Adropin was decreased by the intervention of exogenous Adropin.Compared with ND group,serum TC,LDL-C,ox-LDL,HDL-C levels in HFD group increased and body weight increased,but No effect to TG,whereas Adropin intervention failed to reduce the blood lipid and body weight.Cell experiment:Compared with Control,H2O2 promoted the morphological change of endothelial cells(especially on the 6th day),which showed the increase of spindle cells andα-SMA positive cells.At the same time,the expression of mRNA and protein of endothelial cell markers(CD31 and VE-cadherin)decreased,while the expression of mesenchymal cells markers(α-SMA,SM22α),signal pathway related factors(TGF-β1 and TGF-β2),and downstream signal protein P(phosphorylation)-Smad2/3 in TGF-βincreased.Adropin reversed the above changes[H2O2+Adropin vs H2O2,spindle cells,(0.19±0.05)vs(0.57±0.07)%,P<0.05;α-SMA positive cells,(0.10±0.04)vs(0.93±0.01)%,P<0.05][p-Smad2/3,Control,(0.36±0.25);H2O2,(0.74±0.31);Adropin(0.34±0.21),Adropin vs H2O2,P<0.05].Transfection of TGF-β(Adropin+TGF-βgroup)inhibited the above-mentioned effects of Adropin on endothelial cell interstitial transformation and inhibited the TGF-β/Smad2/3 signaling pathway.Conclusions:Adropin can alleviate atherosclerosis in mice through non-lipid-regulating pathway,and its mechanism may be related to the inhibition of endothelial-mesenchymal transition.TGF-β/Smad2/3 signaling pathway is involved in the above-mentioned process. |